NCT03046693View on ClinicalTrials.gov

Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

April 30, 2017

Study Completion Date

May 31, 2017

Conditions
Non-arteritic Anterior Ischemic Optic Neuropathy
Interventions
DRUG

Group A Citicoline 1000 mg oral tablet

Citicoline 1000 mg will be repackaged and given to Group A for 60 days

DRUG

Group B placebo oral tablet

Placebo will be repackaged and given to Group B for 60 days

Trial Locations (1)

10320

Departemen Mata Fakultas Kedokteran Universitas Indonesia- RSCM Kirana, Jakarta

All Listed Sponsors
lead

Valen Chia

OTHER

NCT03046693 - Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) | Biotech Hunter | Biotech Hunter